Provided by Tiger Fintech (Singapore) Pte. Ltd.

10x Genomics, Inc.

8.43
+0.33004.07%
Post-market: 8.520.0900+1.07%16:01 EDT
Volume:3.19M
Turnover:27.00M
Market Cap:1.04B
PE:-5.56
High:8.59
Open:8.43
Low:8.23
Close:8.10
Loading ...

AI Biotech Stocks Shined, with Recursion and Tempus Jumping 5%

Tiger Newspress
·
24 Feb

10x Genomics unveils roadmap at AGBT general meeting

TIPRANKS
·
24 Feb

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

PR Newswire
·
24 Feb

Genetics Tools Face Fund Cuts -- Barron's

Dow Jones
·
15 Feb

10x Genomics (TXG) Receives a Buy from Morgan Stanley

TIPRANKS
·
14 Feb

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
14 Feb

Morgan Stanley Trims Price Target on 10x Genomics to $26 From $28, Keeps Overweight Rating

MT Newswires Live
·
14 Feb

10x Genomics Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
14 Feb

10x Genomics price target lowered to $15 from $18 at Barclays

TIPRANKS
·
14 Feb

10x Genomics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
14 Feb

Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties

Benzinga
·
14 Feb

Why 10x Genomics (TXG) Shares Are Falling Today

StockStory
·
14 Feb

UBS Adjusts Price Target on 10x Genomics to $14 From $20, Keeps Neutral Rating

MT Newswires Live
·
13 Feb

10x Genomics Shares Down 4% After Bigger-Than-Expected Q4 Loss

THOMSON REUTERS
·
13 Feb

10x Genomics Shares Tumble on Fear Over Cuts to NIH -- Barrons.com

Dow Jones
·
13 Feb

Leerink Partners Downgrades 10x Genomics to Market Perform From Outperform, Adjusts Price Target to $12 From $25

MT Newswires Live
·
13 Feb

Q4 2024 10X Genomics Inc Earnings Call

Thomson Reuters StreetEvents
·
13 Feb

10x Genomics Inc : Leerink Partners Cuts to Market Perform From Outperform

THOMSON REUTERS
·
13 Feb

BUZZ-10x Genomics falls on disappointing 2025 sales forecast

Reuters
·
13 Feb

Stock Track | 10x Genomics Plunges 9.83% Pre-Market on NIH Funding Cuts and Weak Guidance

Stock Track
·
13 Feb